University of California, San Francisco (UCSF)
San Francisco, California, 94143, United States
NCT Number: NCT02470936
A randomized controlled trial of a technology-based lifestyle intervention vs. usual care among men with low-risk prostate cancer to determine the feasibility and acceptability of the intervention and the effect of the intervention on behavior change related to exercise, diet, and not smoking.
Looking for future studies?
Notify Me18 year and older
Male
Interventional
Not applicable
San Francisco, California, 94143, United States
This is a PI-initiated, randomized, unblinded, clinical trial of a technology-based 3 month lifestyle intervention vs. usual care among men with low risk prostate cancer. We will recruit and consent 76 men with prostate cancer at UCSF. The subjects will be asked to complete questionnaires, 7 days accelerometer measurement, body measurements (weight, waist, hip, pulse, blood pressure) and collection of blood specimen at baseline and 3 months. Subjects will be randomized into two arms (Intervention Group and Control Group). The Intervention Group (N=38) will have access to the lifestyle website and an activity monitor (e.g., Fitbit), receive text messages, and be provided with individualized lifestyle recommendations. The Control Group (N=38) will have standard of care and be asked to continue with their usual lifestyle habits. They will receive access to the lifestyle website and be provided with individualized lifestyle recommendations at 3 months.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients will have access to the lifestyle website and an activity monitor (e.g., Fitbit), receive texts, and be provided with individualized lifestyle recommendations.
Time frame: 3 months
We will measure the number of days the Fitbit was used during the study period in the intervention arm only to assess study feasibility
Time frame: 3 months
We will measure the number of text messages responded to that required a reply in the intervention arm only during the study period to assess study feasibility
Time frame: 3 months
We will measure the total number of days the website was visited in the intervention arm only during the study period to assess study feasibility
Time frame: 3 months
We will measure the total number of website visits in the intervention arm only during the study period to assess study feasibility
Time frame: 3 months
We will assess intervention acceptability via questionnaire at 3 months in the intervention group.
Time frame: 3 months
We will assess change in health behaviors via questionnaire at baseline and 3 months.
Time frame: 3 months
This is assessed via 7-day accelerometer measurements at baseline and 3 months.
Time frame: 3 months
We will assess confidence in performing behaviors via questionnaire at baseline and 3 months.
Time frame: 3 months
We will assess Vitamin E levels at baseline and 3 months.
Time frame: 3 months
We will assess lycopene levels at baseline and 3 months.
Time frame: 3 months
We will assess fasting glucose at baseline and 3 months.
Time frame: 3 months
We will assess cholesterol at baseline and 3 months.
Time frame: 3 months
We will assess hemoglobin A1c at baseline and 3 months.
Time frame: 3 months
We will assess C-reactive protein at baseline and 3 months.
Time frame: 3 months
We will assess waist circumference at baseline and 3 months.
Time frame: 3 months
We will assess weight at baseline and 3 months.
Time frame: 3 months
We will assess body mass index at baseline and 3 months.
Time frame: 3 months
Center for Epidemiologic Studies Depression Scale completed at baseline and 3 months.
Time frame: 3 months
Memorial Anxiety Scale for Prostate Cancer and State Anxiety completed at baseline and 3 months. Trait anxiety completed at baseline.
Time frame: 3 months
Expanded Prostate Cancer Index Composite-26 and Short Form Health Survey-36 completed at baseline and 3 months.
Time frame: 1 year
We will assess change in health behaviors via questionnaire at baseline, 3 months, and 1 year.
University of California, San Francisco
Other
A Randomized Clinical Trial of Web-based Lifestyle Tools and Resources Versus Usual Care Among Men With Prostate Cancer
Acronym: Prostate 8
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03269422
Genital Diseases, Genital Diseases, Male
Basking Ridge, New Jersey, United States
View Trial DetailsNCT05754658
Breast Cancer, Breast Diseases
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT03606837
Genital Diseases, Genital Diseases, Male
Bordeaux, France
View Trial DetailsNCT06540794
Genital Diseases, Genital Diseases, Male
Istanbul, Turkey (Türkiye)
View Trial Details